Cost Analysis of Immunoglobulin Maintenance Treatment of Patients with Chronic Inflammatory Demyelinating Polyneuropathy in Spain
Overall, the findings of this analysis suggest that SCIG may be a cost-saving alternative to IVIG for patients with CIDP requiring maintenance treatment in Spain, with a similar cost between c-SCIG and f-SCIG.
Authors
- L. Querol
- Sofía de Pedro
- Josep Gámez (ORCID: https://orcid.org/0000-0003-3127-7486)
- F. Gómez Fernández
- María Presa
Institutions
- Hospital de Sant Pau (ES)
- Centre for Biomedical Network Research on Rare Diseases (ES)
- Centro de Investigación Biomédica en Red (ES)
- Hospital Clínic de Barcelona (ES)
- Hospital General de Catalunya (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Pharmacoeconomics and Health Outcomes Research Iberia (Spain) (ES)
Publication Details
- Journal
- PharmacoEconomics - Open
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1007/s41669-025-00633-8
- Primary Topic
- Peripheral Neuropathies and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00